We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GenoLogics to Provide Illumina with LIMS for HiSeq X Ten System
News

GenoLogics to Provide Illumina with LIMS for HiSeq X Ten System

GenoLogics to Provide Illumina with LIMS for HiSeq X Ten System
News

GenoLogics to Provide Illumina with LIMS for HiSeq X Ten System

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "GenoLogics to Provide Illumina with LIMS for HiSeq X Ten System"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Under the agreement, the companies are working closely to provide support for HiSeq X Ten whole-genome workflows and analysis pipelines, including those to be used inside of Illumina. Additionally, Illumina will be using GenoLogics’ LIMS to support its collaboration with Genomics England to sequence 100,000 genomes.

The agreement pairs the $1,000 genome with the preeminent laboratory information management system, further empowering the sequencing community to sequence human whole genomes.

According to Alex Dickinson, Senior Vice President of Strategic Initiatives at Illumina, “Illumina is pleased to be working with GenoLogics to ensure HiSeq X Ten customers receive the LIMS support they need. Scaling a lab to deliver the $1,000 genome presents unique challenges and GenoLogics has the demonstrated ability and understanding of our technologies to support these labs.”

“Clarity LIMS leads the industry because it helps sequencing labs improve overall efficiency, turnaround time, and the accuracy of data,” states Michael Ball, CEO of GenoLogics. “This agreement was the logical next step with Illumina because it builds on these efficiencies with enhanced automation and throughput, enabling customers to rapidly scale their sequencing operations.”

Advertisement